Overview (18 Sep 2026)
Alpa Laboratories Ltd
ALPA
INE385I01010

Pharmaceuticals
Result was last declared on 14 Aug 2026
-0.29

Prev. Close
Previous Close
59.64
Current Close
59.35
Current High
60.85
Current Low
58.51
52 Week High
99.75
52 Week Low
46
Resistance 1
60.63
Resistance 2
61.91
Support 1
58.29
Support 2
55.95
Std Deviation
5.07%
DMA 200
68.40
DMA 50
65.21
DMA 20
62.16
Fundamentals and Ratios
Standalone
Trailing EPS
6.69
Forwad EPS
2.73
Trailing P/E
8.87
Forward P/E
21.71
PEG Ratio
-0.40
Mkt. Cap (Cr)
Market Cap (Cr)
124.88
Total Debt(Cr)
Tot. Debt(Cr)
2.51
Reserve (Cr)
165.24
Book Value
93.14
P/BV Ratio
0.64
ROCE(%)
3.00
ROE
3.00
Consolidated
Trailing EPS
6.71
Forwad EPS
2.17
Trailing P/E
8.85
Forward P/E
27.31
PEG Ratio
-0.47
Mkt. Cap (Cr)
Market Cap (Cr)
124.88
Total Debt(Cr)
Tot. Debt(Cr)
2.51
Reserve (Cr)
165.24
Book Value
88.70
P/BV Ratio
0.67
ROCE(%)
2.83
ROE
1.8700

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue23.9331.429.6725.6319.11105.81
Other Income5.83-0.180.263.6911.9615.72
Total Income29.7631.2129.9329.3231.07121.53
Interest0.110.160.030.050.050.29
Expenditure-28.72-28.17-28.21-29.22-19.29-104.89
PBDT0.000.000.000.000.000.00
Depreciation-0.72-0.22-0.65-0.67-0.55-2.09
PBT1.043.041.720.1011.7816.64
Tax0.00-1.690.160.000.00-1.69
Equity21.0421.040.000.0021.0421.04
OPM3.499.745.790.3937.9113.69
Net Profit1.041.361.880.111.7814.95
NPM3.494.366.320.3937.9112.3
EPS0.520.640.890.055.66.69
Consolidated
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue23.9331.429.0526.2619.11105.81
Other Income5.77-0.160.913.0611.9415.76
Total Income29.7031.2429.9629.3231.06121.57
Interest0.110.150.030.030.050.26
Expenditure-28.72-28.17-28.21-29.21-19.29-104.87
PBDT0.000.000.000.000.000.00
Depreciation-0.72-0.22-0.65-0.67-0.55-2.09
PBT0.982.191.750.1111.7715.81
Tax0.00-1.690.160.000.00-1.69
Equity21.0421.040.000.0021.0421.04
OPM3.307.015.830.3837.8913.01
Net Profit0.980.51.90.1111.7714.13
NPM3.31.66.350.3837.8911.62
EPS0.490.240.90.055.596.71
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings